Table V.
Main outcomes for all included patients
| Study | Death | Amputations | Cardiac | Other complications | Improvement of the ischemia | Mean follow-up | Late outcomes |
|---|---|---|---|---|---|---|---|
| Veerasuri et al9 | 0 | 0 | 0 | 0 | 1 | 2 months | Numbness in right foot |
| Kaur et al10 | 1 | 0 | 1 | Hemodialysis | 0 | NR | NR |
| Brugliera et al11 | 0 | 3 (all TF) | 0 | DVT (n = 1) | 1 | NR | NR |
| Hanif et al12 | 0 | 0 | 0 | 0 | 1 | NR | NR |
| Hasan et al13 | 0 | 1 (TF) | 0 | 0 | 0 | NR | NR |
| Gubitosa et al14 | 1 | 1 (TF) | 1 | HIT | 0 | NR | NR |
| Anwar et al15 | 0 | 1 (below ankle) | 0 | 0 | 0 | NR | NR |
| Singh et al16 | 0 | 0 | 0 | 0 | NR | NR | NR |
| Wang et al17 | 2 | 0 | 0 | Encephalopathy (n = 1) | 0 | NR | NR |
| Goldman et al18 | 6 | 4 (all TF) | NR | NR | NR | NR | NR |
| Sánchez et al19 | 7 | 9 (all TF) | NR | NR | 26 | NR | NR |
| Galanis et al20 | 1 | 0 | 0 | DVT | 0 | NR | NR |
| Bozzani et al21 | 1 | 1 (TF) | 0 | Rethrombosis (n = 2) | 5 | NR | NR |
| Mietto et al22 | 0 | 0 | 0 | Rhabdomyolysis, acute renal failure | 1 | 40 days | Superficial peroneal nerve impairment |
| Baccellieri et al23 | 0 | 0 | 0 | Nephrotic syndrome, bilateral acroischemia, thrombosis of upper limb (intraoperative) | 1 | 2 months | No new event |
| Shao et al24 | 0 | 0 | 0 | PE, GI bleeding | 1 | 2 months | Dry gangrene of digits |
| Etkin et al25 | 17 | 9 (NR) | NR | NR | NR | NR | NR |
| Muhammad et al26 | 0 | 0 | 0 | NR | 1 | 6 weeks | Full recovery |
| Heald et al27 | 0 | 0 | 0 | 0 | NR | NR | NR |
| Bellosta et al28 | 8 | 1 (major) | 1 | NR | NR | NR | NR |
| Kaur et al29 | 1 | 0 | 1 | NR | 1 | NR | NR |
| Kahlberg et al30 | 12 | NR | NR | NR | NR | NR | NR |
| Schultz et al31 | 1 | 0 | 0 | Septic shock, ARDS, AKI (n = 2) DVT (n = 2) Hemorrhagic shock (n = 1) |
1 | NR | NR |
| Vacirca et al32 | 0 | 0 | 0 | 0 | 1 | NR | NR |
| Fan et al33 | 0 | 0 | 0 | NR | 1 | NR | NR |
| Perini et al34 | 1 | 0 | 0 | 0 | 1 | NR | NR |
| Kashi et al35 | 0 | 2 (NR) | NR | DVT (n = 1) | 3 | NR | NR |
| Baeza et al36 | 0 | 0 | 0/3 | 0 | 3 | NR | NR |
| Garg et al37 | 1 | 0 | 0 | DVT (n = 1) Stroke (n = 1) |
2 | NR | NR |
| Thompson et al38 | 0 | 0 | 0 | – | 1 | Several days | Digit tip gangrene |
| Levolger et al39 | 0 | 0 | 0 | Contralateral limb ischemia (n = 1) | 1 | NR | NR |
| Wengerter et al40 | 0 | 1 (BTK) | 0 | Stroke (n =1) | 2 | NR | NR |
| Chowdhury et al41 | 0 | 0 | 0 | 0 | 1 | NR | NR |
| Liu et al42 | 1 | 1 (TF) | 0 | 0 | 0 | NR | NR |
| Total (n) | 61 | 34 (1 study NR) | 4 (5 studies NR) | DVT/PE (n = 7) Rethrombosis (n = 2) Stroke (n = 1) AKI/hemodialysis (n = 4) Encephalopathy (n = 1) Shock (n = 2) Other limb ischemia (n = 2) Rhabdomyolysis (n = 1) HIT (n = 1) Other (n = 3) (8 studies NR) |
56 (6 studies NR) | 0-2 months (28 studies NR) | No new event (n = 2) Digit gangrene (n = 2) Numbness/nerve impairment (n = 2) (28 studies NR) |
ARDS, Acute respiratory distress syndrome; AKI, acute kidney injury; BTK, below the knee; DVT, deep vein thrombosis; GI, gastrointestinal; HIT, heparin-induced thrombopenia; NR, not reported; PE, pulmonary embolism; TF, transfemoral.